产品名称：Human Complement Factor D Antibody (Lampalizumab, Research Use)
产品编号：NBR-0611
针对靶点：Complement Factor
抗体药商品名：DLampalizumab
抗体药描述：Lampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody that binds to complement factor D; it was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration. 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: Complement Factor D
Synonyms: ADN; PFD; DF
Target Description: CFD (Complement Factor D) is a Protein Coding gene. Diseases associated with CFD include Complement Factor D Deficiency and Meningococcemia. Among its related pathways are Initial triggering of complement and Response to elevated platelet cytosolic Ca2+. Gene Ontology (GO) annotations related to this gene include serine-type endopeptidase activity and serine-type peptidase activity. An important paralog of this gene is F12.
Ensembl: ENSG00000197766
Uniprot: P00746